Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials.
Objective To provide a meta-level comparison of standardized safety profiles ('gestalt') of currently licensed biologic and targeted synthetic disease-modifying anti-rheumatic drugs (bDMARDs and tsDMARDs) in rheumatoid arthritis (RA) from pivotal clinical trials. Methods We systematically searched E...
| Publicado en: | Rheumatology Vol. 65; no. 7; pp. 1 - 11 |
|---|---|
| Autores principales: | , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |